{"id":"https://openalex.org/W2012784399","doi":"https://doi.org/10.1002/ana.410310404","title":"Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission","display_name":"Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission","alternate_titles":[],"publication_year":1992,"publication_date":"1992-04-01","ids":{"openalex":"https://openalex.org/W2012784399","doi":"https://doi.org/10.1002/ana.410310404","mag":"2012784399","pmid":"https://pubmed.ncbi.nlm.nih.gov/1350190"},"language":"en","primary_location":{"id":"doi:10.1002/ana.410310404","doi":"https://doi.org/10.1002/ana.410310404","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ana.410310404","pdf_url":null,"source":{"id":"https://openalex.org/S114530997","display_name":"Annals of Neurology","issn_l":"0364-5134","issn":["0364-5134","1531-8249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012784399"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088823694","display_name":"Paolo Calabresi","orcid":"https://orcid.org/0000-0003-0326-5509","observed_orcids":["https://orcid.org/0000-0003-0326-5509"]},"institutions":[{"id":"https://openalex.org/I116067653","display_name":"University of Rome Tor Vergata","ror":"https://ror.org/02p77k626","country_code":"IT","type":"education","lineage":["https://openalex.org/I116067653"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Paolo Calabresi","raw_affiliation_strings":["Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Italy","Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Italy","institution_ids":["https://openalex.org/I116067653"]},{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000717526","display_name":"Marco De Murtas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I116067653","display_name":"University of Rome Tor Vergata","ror":"https://ror.org/02p77k626","country_code":"IT","type":"education","lineage":["https://openalex.org/I116067653"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marco De Murtas","raw_affiliation_strings":["Clinica Neurologica, Dip. Sanita\u0300, II Universita\u0300 degli Studi di Roma, Rome, Italy","Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanita\u0300, II Universita\u0300 degli Studi di Roma, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]},{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082528797","display_name":"Nicola Biagio Mercuri","orcid":"https://orcid.org/0000-0001-6700-7491","observed_orcids":["https://orcid.org/0000-0001-6700-7491"]},"institutions":[{"id":"https://openalex.org/I116067653","display_name":"University of Rome Tor Vergata","ror":"https://ror.org/02p77k626","country_code":"IT","type":"education","lineage":["https://openalex.org/I116067653"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicola Biagio Mercuri","raw_affiliation_strings":["Clinica Neurologica, Dip. Sanita\u0300, II Universita\u0300 degli Studi di Roma, Rome, Italy","Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanita\u0300, II Universita\u0300 degli Studi di Roma, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]},{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021429755","display_name":"Giorgio Bernardi","orcid":"https://orcid.org/0000-0001-8630-6657","observed_orcids":["https://orcid.org/0000-0001-8630-6657"]},"institutions":[{"id":"https://openalex.org/I116067653","display_name":"University of Rome Tor Vergata","ror":"https://ror.org/02p77k626","country_code":"IT","type":"education","lineage":["https://openalex.org/I116067653"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giorgio Bernardi","raw_affiliation_strings":["Clinica Neurologica, Dip. Sanita\u0300, II Universita\u0300 degli Studi di Roma, Rome, Italy","Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanita\u0300, II Universita\u0300 degli Studi di Roma, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]},{"raw_affiliation_string":"Clinica Neurologica, Dip. Sanit\u00e0, II Universit\u00e0 degli Studi di Roma, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088823694"],"corresponding_institution_ids":["https://openalex.org/I116067653"],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":null,"fwci":4.8056,"has_fulltext":false,"cited_by_count":84,"citation_normalized_percentile":{"value":0.95226695,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"31","issue":"4","first_page":"366","last_page":"373"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.4966000020503998,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.4966000020503998,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.43549999594688416,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.025499999523162842,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-neuroleptic-treatment","display_name":"chronic neuroleptic treatment","score":0.9819999933242798},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.871999979019165},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.7870000004768372},{"id":"https://openalex.org/keywords/presynaptic-inhibition","display_name":"presynaptic inhibition","score":0.9769999980926514},{"id":"https://openalex.org/keywords/glutamate-release","display_name":"glutamate release","score":0.9129999876022339},{"id":"https://openalex.org/keywords/movement-disorders","display_name":"movement disorders","score":0.7020000219345093},{"id":"https://openalex.org/keywords/gabaergic-transmission","display_name":"GABAergic neurotransmission","score":0.5509999990463257},{"id":"https://openalex.org/keywords/cholinergic-transmission","display_name":"cholinergic neurotransmission","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.743533730506897},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.717753529548645},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6668123602867126},{"id":"https://openalex.org/C197341189","wikidata":"https://www.wikidata.org/wiki/Q863533","display_name":"Postsynaptic potential","level":3,"score":0.6367369890213013},{"id":"https://openalex.org/C112592302","wikidata":"https://www.wikidata.org/wiki/Q1207387","display_name":"Excitatory postsynaptic potential","level":3,"score":0.6040775775909424},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.578986644744873},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5376319885253906},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.5246841311454773},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.5198115110397339},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.501631498336792},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4540165662765503},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.44081786274909973},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.4206802546977997},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38736099004745483},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37512820959091187},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36513254046440125},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31768423318862915},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2802894115447998},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20614078640937805}],"mesh":[{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005973","descriptor_name":"Glutamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010277","descriptor_name":"Parasympathomimetics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019257","descriptor_name":"Quinpirole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ana.410310404","doi":"https://doi.org/10.1002/ana.410310404","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ana.410310404","pdf_url":null,"source":{"id":"https://openalex.org/S114530997","display_name":"Annals of Neurology","issn_l":"0364-5134","issn":["0364-5134","1531-8249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Neurology","raw_type":"journal-article"},{"id":"pmid:1350190","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1350190","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of neurology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W253326700","https://openalex.org/W1568768559","https://openalex.org/W1880252216","https://openalex.org/W1928463227","https://openalex.org/W1967970191","https://openalex.org/W1970855023","https://openalex.org/W1972053345","https://openalex.org/W1974439801","https://openalex.org/W1978112166","https://openalex.org/W1978808476","https://openalex.org/W1982254637","https://openalex.org/W1982822260","https://openalex.org/W1983406467","https://openalex.org/W1991603311","https://openalex.org/W1997485587","https://openalex.org/W1997663656","https://openalex.org/W2002416605","https://openalex.org/W2009447429","https://openalex.org/W2014486882","https://openalex.org/W2024696043","https://openalex.org/W2026306356","https://openalex.org/W2028332584","https://openalex.org/W2028875150","https://openalex.org/W2030683825","https://openalex.org/W2033041856","https://openalex.org/W2038054494","https://openalex.org/W2042272150","https://openalex.org/W2045834410","https://openalex.org/W2049977718","https://openalex.org/W2050879667","https://openalex.org/W2051709511","https://openalex.org/W2053959292","https://openalex.org/W2055681098","https://openalex.org/W2056497395","https://openalex.org/W2056831293","https://openalex.org/W2066003859","https://openalex.org/W2074657360","https://openalex.org/W2077657160","https://openalex.org/W2077907524","https://openalex.org/W2080254657","https://openalex.org/W2086608701","https://openalex.org/W2088866753","https://openalex.org/W2103552759","https://openalex.org/W2104302486","https://openalex.org/W2115444744","https://openalex.org/W2135727783","https://openalex.org/W2290734809","https://openalex.org/W2294946349","https://openalex.org/W2333142638","https://openalex.org/W2492369133","https://openalex.org/W4241267009"],"related_works":["https://openalex.org/W2105386949","https://openalex.org/W2040255246","https://openalex.org/W2086790602","https://openalex.org/W2045944378","https://openalex.org/W2029442804","https://openalex.org/W2006110990","https://openalex.org/W2091793118","https://openalex.org/W2081637291","https://openalex.org/W2023130029","https://openalex.org/W1972251843"],"abstract_inverted_index":{"We":[0],"studied":[1],"the":[2,42,47,98],"in":[3,87],"vitro":[4],"electrical":[5],"activity":[6],"of":[7,22,32,46,92,100],"rat":[8],"neostriatal":[9,23,48],"neurons":[10],"following":[11],"chronic":[12,69,80],"neuroleptic":[13,81],"treatment.":[14,71],"In":[15],"haloperidol-treated":[16],"rats,":[17],"unlike":[18],"naive":[19],"animals,":[20],"activation":[21],"D2":[24,94],"dopamine":[25,95],"receptors":[26,96],"induced":[27,78],"a":[28,90],"potent":[29],"presynaptic":[30,93],"inhibition":[31],"glutamate-mediated":[33],"excitatory":[34],"synaptic":[35],"potentials.":[36],"Haloperidol":[37],"treatment":[38,82],"did":[39],"not":[40,66],"affect":[41],"intrinsic":[43],"membrane":[44],"properties":[45],"neurons.":[49],"Pre-":[50],"and":[51,57,62],"postsynaptic":[52],"physiological":[53],"responses":[54],"to":[55],"direct":[56],"indirect":[58],"gamma-aminobutyric":[59],"acid":[60],"(GABA)-ergic":[61],"cholinergic":[63],"agonists":[64],"were":[65],"affected":[67],"by":[68,79],"haloperidol":[70],"These":[72],"findings":[73],"suggest":[74],"that":[75],"movement":[76],"disorders":[77],"may":[83],"result,":[84],"at":[85],"least":[86],"part,":[88],"from":[89],"hypersensitivity":[91],"regulating":[97],"release":[99],"glutamate.":[101]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012784399","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
